Position in ABUS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$818,179
+$94,849 QoQ
Shares Held
170,454
+6.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 175 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. ABUS ranks #149 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ABUS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $818,179 | 170,454 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $723,330 | 160,740 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $674,351 | 140,198 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $598,480 | 131,824 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $351,351 | 113,706 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $512,551 | 146,863 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $561,674 | 171,766 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $371,732 | 96,554 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $224,936 | 72,795 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $187,973 | 72,858 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $166,359 | 66,544 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $140,776 | 69,348 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $127,672 | 55,510 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $218,028 | 71,957 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $117,107 | 50,261 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $94,622 | 49,541 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $153,813 | 56,758 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $129,790 | 43,554 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $189,832 | 48,800 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $198,266 | 46,216 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,138,531 | 375,753 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $175,048 | 52,567 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $399,967 | 127,785 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||